A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
12/1998
12/30/1998	EP0886654A1 Thioureido-cyclodextrins particularly useful for solubilising antitumoral and antiparasitic agents, and methods for preparing same
12/30/1998	EP0886651A1 Persephin and related growth factors
12/30/1998	EP0886636A1 Novel piperidines derived from 1-/(piperazin-1-yl)aryl(oxy/amino)carbonyl/-4-aryl-piperidine as selective 5-ht-1d.beta. receptor antagonists
12/30/1998	EP0886519A1 Sustained release formulation containing dfmo
12/30/1998	EP0766688A4 Synthesis of oligonucleotides
12/30/1998	EP0750637B1 Dna encoding cai resistance proteins and uses thereof
12/30/1998	EP0594577B1 Novel potent inducers of terminal differentiation and method of use thereof
12/30/1998	CN1203633A Diagnosis of susceptibility to cancer and treatment thereof
12/30/1998	CN1203632A P16 expression constructs and their application in cancer therapy
12/30/1998	CN1203603A Therapeutic compounds comprised of anti-FC receptor antibodies
12/30/1998	CN1203598A Farnesyl protein transferase inhibiting (imidazol-5-yl) methyl-2-quinolinone derivatives
12/30/1998	CN1203590A Substituted imidazoles having anti-cancer and cytokine inhibitory activity
12/30/1998	CN1203528A Use of gamma-RAR-specific agonist ligand to increase apoptosis rate
12/30/1998	CN1041383C Method of preparing composition for effective depressing of woman ovulation
12/30/1998	CA2294646A1 Human catalytic telomerase sub-unit and its diagnostic and therapeutic use
12/30/1998	CA2294606A1 Soluble prodrugs of paclitaxel
12/30/1998	CA2294259A1 Barbituric acid derivatives with antimetastatic and antitumor activity
12/30/1998	CA2294187A1 Device for projection mammography
12/30/1998	CA2294050A1 New .beta.-amino and .beta.-azidocarboxylic acid derivatives, the production thereof and the use thereof as endothelin receptor antagonists
12/30/1998	CA2293833A1 Compositions and methods for activating genes of interest
12/30/1998	CA2293327A1 Method for the treatment of cancer with exochelins of mycobacterium tuberculosis
12/29/1998	US5854411 Human chloride channel
12/29/1998	US5854404 Antitumor substance extracted from grifola
12/29/1998	US5854289 Guanylhydrazones and their use to treat inflammatory conditions
12/29/1998	US5854277 Thiophenebutanoic acid derivatives as matrix metalloprotease inhibitors
12/29/1998	US5854273 Bisimide compounds
12/29/1998	US5854244 Melamine derivatives for use in the treatment of cancer
12/29/1998	US5854240 Methylene blue for the treatment or prophylaxis of encephalopathy caused by ifosfamide
12/29/1998	US5854234 Amidino dervatives useful as nitric oxide synthase inhibitors
12/29/1998	US5854231 Pharmaceutical composition for inhibiting the growth of cancers
12/29/1998	US5854220 Glial mitogenic factors, their preparation and use
12/29/1998	US5854202 Peptide fragments of calreticulin, peptide mimetics thereof, and pharmaceutical compostions comprising same
12/29/1998	US5854044 Recombinant pseudomonas exotoxin with increased activity
12/29/1998	US5854022 Polynucleotides encoding a CD53-like transmembrane protein
12/29/1998	US5854007 Process for producing GM1 specific antibodies
12/29/1998	US5853997 Human protein phosphatase
12/29/1998	US5853976 Recombinant proteinase from clostridium histolyticum and its use for isolating cells and groups of cells
12/29/1998	US5853719 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
12/29/1998	US5853695 Method for palliation of pain in human bone cancer using therapeutic tin-117m compositions
12/29/1998	US5853623 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases
12/29/1998	CA2171281C Immunomodulating compositions from bile
12/29/1998	CA2150265C Activation of p53 protein
12/29/1998	CA2129554C Recombinant antibodies specific for tnf-.alpha.
12/29/1998	CA1340297C Conjugation of polymer to colony stimulating factor-1
12/29/1998	CA1340296C Cell growth regulatory factor
12/29/1998	CA1340295C Human somatomedin carrier protein subunits and process for procucing them
12/29/1998	CA1340291C Oxaspiro ¬2,5\| octane derivative
12/24/1998	DE19726282A1 Nanoskalige Teilchen mit einem von mindestens zwei Schalen umgebenen eisenoxid-haltigen Kern Nanoscale particles having an area surrounded by at least two shells in iron oxide-containing core
12/24/1998	DE19722846A1 Leukotrien-B¶4¶-Derivate, insbesondere 7-Methylcyclohexyl-LTB¶4¶-Antagonisten Leukotriene B¶4¶ derivatives, in particular 7-methylcyclohexyl-LTB¶4¶ antagonists
12/24/1998	CA2234418A1 Human afc1
12/24/1998	CA2234402A1 Human rce1
12/23/1998	WO1998058066A1 New human lysophospholipase
12/23/1998	WO1998057987A2 Irs-p53h, human insulin receptor tyrosine kinase substrate
12/23/1998	WO1998057976A1 Secreted proteins and polynucleotides encoding them
12/23/1998	WO1998057970A1 Benzo(5,6)cycloheptapyridine compounds useful as farnesyl protein transferase inhibitors
12/23/1998	WO1998057968A1 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives useful for inhibition of farnesyl protein transferase
12/23/1998	WO1998057965A1 Novel aminooxyamide tricyclic inhibitors of farnesylprotein transferase
12/23/1998	WO1998057963A1 Benzo(5,6)cycloheptapyridine cyclic ureas and lactams useful as farnesyl protein transferase inhibitors
12/23/1998	WO1998057962A1 Benzo(5,6)cyclohepta(1,2b)pyridine derivatives useful for inhibition of farnesyl protein transferase
12/23/1998	WO1998057961A1 Bispyrido-cycloheptane compounds useful for inhibition of farnesyl protein transferase
12/23/1998	WO1998057960A1 Benzpyrido cycloheptane compounds useful for inhibition of farnesyl protein transferase
12/23/1998	WO1998057959A1 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives for the inhibition of farnesyl protein transferase
12/23/1998	WO1998057956A1 Bis(9-aminoacridine) dna intercalating agents having antitumor a activity
12/23/1998	WO1998057955A1 Compounds useful for inhibition of farnesyl protein transferase
12/23/1998	WO1998057950A1 Novel phenyl-substituted tricyclic inhibitors of farnesyl-protein transferase
12/23/1998	WO1998057949A1 Novel tricyclic sulfonamide inhibitors of farnesyl-protein transferase
12/23/1998	WO1998057948A1 Novel n-substituted urea inhibitors of farnesyl-protein transferase
12/23/1998	WO1998057947A1 Tricyclic keto amide derivatives useful as farnesyl protein transferase inhibitors
12/23/1998	WO1998057946A1 Carboxy piperidylacetamide tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases (farnesyl protein transferase inhibitors)
12/23/1998	WO1998057945A1 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives as farnesyl protein transferase inhibitors
12/23/1998	WO1998057944A1 Benzo(5,6)cyclohepta(1,2b)pyridine derivatives useful for inhibition of farnesyl protein transferase
12/23/1998	WO1998057939A1 Crystalline roxifiban
12/23/1998	WO1998057936A1 Quinoline derivatives as pde iv and/or tnf inhibitors
12/23/1998	WO1998057668A1 Diagnostic agents and remedies for malignant tumors
12/23/1998	WO1998057662A2 Therapeutic systems
12/23/1998	WO1998057660A1 Adjuvant compositions for vaccines
12/23/1998	WO1998057659A1 Adjuvant compositions for vaccines
12/23/1998	WO1998057633A1 FARNESYL TRANSFERASE INHIBITORS IN COMBINATION WITH HMG CoA REDUCTASE INHIBITORS FOR THE TREATMENT OF CANCER
12/23/1998	EP0885960A2 G-protein coupled receptor (H7TBA62)
12/23/1998	EP0885959A2 Human Wnt-5b protein
12/23/1998	EP0885956A1 Pharmaceutical composition having an endoproteolytic activity; a process for endoproteolytically processing (precursor) proteins and for the (micro) biological production of proteins
12/23/1998	EP0885616A1 Use of intravenous contrast agents, and apparatus for projectionsmammography
12/23/1998	EP0885614A2 Method of ex vivo immunizing using heterologous intact bispecific and/or trispecific antibodies
12/23/1998	EP0885306A2 Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectors
12/23/1998	EP0885299A1 Wsx receptor and ligands
12/23/1998	EP0885237A1 Oligonucleotide analogues
12/23/1998	EP0885236A1 Oligonucleotide analogs
12/23/1998	EP0885233A1 Terpyridine-platinum(ii) complexes
12/23/1998	EP0885230A1 Camptothecin derivatives and the use thereof as antitumor agents
12/23/1998	EP0885229A1 Fused pyrrolo(2,3-c)carbazole-6-ones which potentiate activity of gamma interferon
12/23/1998	EP0885227A1 PYRIMIDO 5,4-d]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION
12/23/1998	EP0885226A1 4-amino pyrimidine derivates, medicaments containing these compounds, their use and process for their production
12/23/1998	EP0885208A1 Taxoids, their preparation and pharmaceutical compositions containing them
12/23/1998	EP0885017A2 Use of labelled cck-b receptor ligands for the detection and localization of malignant human tumours
12/23/1998	EP0885015A2 Modified cytokines for therapeutic use
12/23/1998	EP0885013A1 New indications for the use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses
12/23/1998	EP0885006A1 Pharmaceutical composition enabling to inhibit cancer metastasis formation containing n-acetyl-cysteine and doxorubicin
12/23/1998	EP0885003A1 Use of hexahydrolupulones as antibacterial and anticancer agents
12/23/1998	EP0728012A4 NOVEL GnRH ANALOGUES WITH ANTITUMOUR EFFECTS AND PHARMACEUTICAL COMPOSITIONS THEREOF
12/23/1998	EP0683762B1 Acylfulvene analogues as antitumor agents

1 ... 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 ... 2211